3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Prostatic Neoplasms
11
Carcinoma, Renal Cell
10
Breast Neoplasms
6
Urinary Bladder Neoplasms
5
Melanoma
4
Neoplasm Metastasis
3
Lymphoma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Wilms Tumor
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Liver Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Interventions
Cyclophosphamide
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
cabozantinib
1
Topotecan
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Mesna
1
Granulocyte Colony-Stimulating Factor
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Clear Cell
×
Sirolimus
×
Genitourinary
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled